本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Alpha Tau Medical

7.23
-0.2250-3.02%
成交量:16.67萬
成交額:120.61萬
市值:6.16億
市盈率:-13.84
高:7.50
開:7.50
低:7.00
收:7.45
52周最高:7.89
52周最低:2.30
股本:8,526.41萬
流通股本:5,713.21萬
量比:0.57
換手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-0.5219
每股收益(LYR):-0.4540
淨資產收益率:-54.38%
總資產收益率:-25.56%
市淨率:7.94
市盈率(LYR):-15.91

資料載入中...

2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/30

SEC問詢函

Form CORRESP - Correspondence
2025/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC問詢函

Form CORRESP - Correspondence
2023/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities